Norges Bank’s Aerie Pharmaceuticals AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-201,601
Closed -$2.3M 2328
2021
Q3
$2.3M Buy
201,601
+148,981
+283% +$2.18M ﹤0.01% 2031
2021
Q2
$842K Sell
52,620
-192,606
-79% -$3.3M ﹤0.01% 2128
2021
Q1
$4.38M Buy
245,226
+250
+0.1% +$4.32K ﹤0.01% 1926
2020
Q4
$3.31M Sell
244,976
-96,746
-28% -$1.17M ﹤0.01% 1911
2020
Q3
$4.02M Sell
341,722
-58,031
-15% -$707K ﹤0.01% 1900
2020
Q2
$5.9M Sell
399,753
-20,435
-5% -$302K ﹤0.01% 1841
2020
Q1
$5.67M Hold
420,188
﹤0.01% 1798
2019
Q4
$10.2M Hold
420,188
﹤0.01% 1796
2019
Q3
$8.08M Buy
420,188
+30,367
+8% +$696K ﹤0.01% 1838
2019
Q2
$11.5M Buy
389,821
+42,765
+12% +$1.65M ﹤0.01% 1756
2019
Q1
$16.5M Buy
347,056
+47,463
+16% +$2.09M 0.01% 1610
2018
Q4
$10.8M Hold
299,593
﹤0.01% 1709
2018
Q3
$18.4M Hold
299,593
0.01% 1576
2018
Q2
$20.2M Hold
299,593
0.01% 1519
2018
Q1
$16.3M Buy
299,593
+41,759
+16% +$2.34M 0.01% 1556
2017
Q4
$15.4M Hold
257,834
0.01% 1579
2017
Q3
$12.5M Buy
+257,834
New +$14.1M ﹤0.01% 1663

Other funds holding AERI

Norges Bank's AERI Position: Q4 2021 in Review

Norges Bank sold out of Aerie Pharmaceuticals (AERI) in Q4 2021, closing a stake of 201,601 shares — an estimated $2.3M sold.

Norges Bank first reported a position in AERI in Q3 2017 and held it in 17 quarters. The position peaked at $20.2M in Q2 2018. 129 funds tracked by Wall St. Rank hold AERI as of Q4 2021.

  • Norges Bank reported no remaining Aerie Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Norges Bank sold 201,601 Aerie Pharmaceuticals shares in Q4 2021, an estimated $2.3M.
  • Norges Bank first reported a position in Aerie Pharmaceuticals in Q3 2017 and held it in 17 quarters.
  • Norges Bank's Aerie Pharmaceuticals position peaked at $20.2M in Q2 2018.
  • 129 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2021.

Based on Norges Bank's 13F filing for Q4 2021, filed 10 Feb 2022.